DEA Investigations
DEA inspections, controlled substance compliance, and Drug Supply Chain Security Act enforcement.
Practitioner Dispensing of Controlled Substances From the Office
Dispensing controlled substances from the office triggers DEA records, labeling, and state permit duties that prescribing alone do…
Pain Agreements and Urine Drug Screens: What DEA and Boards Expect
Treatment agreements, urine drug screens and PDMP checks build the record DEA and medical boards read to judge legitimate prescrib…
Multiple Schedule II Prescriptions and the Rule on Issuing Several at Once
DEA rule 21 CFR 1306.12 lets a prescriber issue multiple Schedule II prescriptions at one visit. Here is what pharmacists must ver…
Judicial Review of a DEA Final Order in the Court of Appeals
What happens after a DEA Administrator's final order: the deadline to petition the Court of Appeals, the stay process, and the sta…
DEA Form 82 Notice of Inspection: What You Are Signing
DEA Form 82 asks a pharmacist to sign away the right to a warrant. What the consent line waives, and when the warrant alternative…
Chain Pharmacy Quotas and DEA Corresponding Responsibility Liability
DOJ settlements with CVS and Walmart in 2026 tie corporate performance metrics and pharmacist staffing to DEA corresponding respon…
Prescribing Stimulants by Telehealth: DEA and State Exposure
Telehealth prescribing of Schedule II stimulants for ADHD runs on a temporary DEA extension, and a November 2025 conviction shows…
DEA Telemedicine Special Registration: Where the Rule Stands
The DEA's telemedicine special registration is still proposed, not final. The controlled-substance prescribing flexibilities run t…
Controlled Substances in Nursing Homes: Disposal and Diversion
DEA's long-term care disposal rule sets a three-business-day clock and a two-employee handling rule. A missing dose opens a divers…